Clinical Trials on Cancer Treatment Induced Thrombocytopenia in Chile

Total 5 results

Pontificia Universidad Catolica de Chile

Completed

Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients

Cancer | Breast Cancer | Esophageal Cancer | Lung Cancer | Cardiotoxicity | Radiotherapy; Complications

Chile
Hospital San Juan de Dios, Santiago

Completed

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Cisplatin Adverse Reaction | Hearing Loss Ototoxic

Chile
European Organisation for Research and Treatment...
ETOP IBCSG Partners Foundation; German Adjuvant Breast Cancer Group

Completed

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer

Breast Cancer | Psychosocial Effects of Cancer and Its Treatment | Sexuality and Reproductive Issues | Sexual Dysfunction and Infertility

Belgium, Switzerland, Peru, Italy, Germany, Netherlands, United Kingdom, Serbia, Chile, Poland, Croatia, Turkey, South Africa, Lebanon, Portugal
Amgen

Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Chemotherapy-induced Thrombocytopenia

United States, Spain, Turkey, Argentina, Greece, Austria, Brazil, Bulgaria, Chile, Colombia, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Ukraine, Hungary
Sandoz
Sandoz GmbH

Completed

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim (PROTECT2)

Breast Cancer | Chemotherapy-induced Neutropenia

Spain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation

Clinical Trials on Cancer Treatment Induced Thrombocytopenia in Chile

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations